Pacific Biosciences of California, Inc. (PACB)

NMS – Real vaqt narxi. Valyuta: USD

1.09

-0.05 (-4.37%)

Bozor ochiq: Aug 12, 2026, 2:52 PM EDT

1.16

+0.02 (1.71%)

Oldingi bozordan keyin: Aug 11, 2026, 7:52 PM EDT

06.08.2026

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.

06.08.2026

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 revenues down, below consensus. Operating and net losses remain sizable, with cash now under $237 million and nearly $645 million in debt outstanding. PACB trades at 2.4x expected 2026 revenues, a steep discount to peers, reflecting weaker financials and growth prospects.

06.08.2026

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

06.08.2026

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California NASDAQ: PACB reported second-quarter 2026 revenue of $39 million, roughly flat from $39.8 million a year earlier, while announcing an immediate leadership transition and lowering its full-year revenue outlook amid a slower-than-expected rollout of its new multi-use sequencing chemistry and continued funding constraints in academic and government markets.

05.08.2026

Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.13 per share a year ago.

05.08.2026

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026 Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026

05.08.2026

PacBio Announces Second Quarter 2026 Financial Results

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

05.08.2026

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

05.08.2026

PacBio Announces Second Quarter 2026 Financial Results

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026.

05.08.2026

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs

Pacific Biosciences of California, Inc. (PACB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Pacific Biosciences of California, Inc. (PACB)

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

Search stocks

Pacific Biosciences of California, Inc. (PACB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Pacific Biosciences of California, Inc. (PACB)

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

PacBio Announces Second Quarter 2026 Financial Results

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system